Literature DB >> 12498968

Screening of two mutations at exon 3 of the apolipoprotein E gene (sites 28 and 42) in a sample of patients with sporadic late-onset Alzheimer's disease.

R Scacchi1, G Gambina, G Ferrari, R M Corbo.   

Abstract

The search for further variation at the APOE gene in a sample of patients with sporadic late-onset Alzheimer's disease (AD) and related controls revealed two different mutations in the exon 3 of the gene. One, the Leu28-->Pro, always found on an APOE e(*)4 allele, was present in five of the 94 patients and in 1 of the 157 controls. The other, Thr42-->Ala, found on an e(*)3 allele, was observed in only one AD patient, who also carried the Leu28-->Pro, but in none of the controls. In the AD patient group the allele e(*)4(-), corresponding to Leu28-->Pro, showed a frequency of 0.027, compared with only 0.003 in the controls. Compared to E3/3 and E3/2 genotypes, the risk of developing AD associated with the genotypes carrying the e(*)4 allele, the well-established risk allele for AD onset, was observed to be high (OR=3.16; 95% CI=1.62-6.20; P=0.0009), but the risk associated with genotypes carrying the Leu28-->Pro mutation was higher still (OR=10.95; 95% CI=1.25-95.75; P=0.015). The higher risk associated with this mutation was assessed by meta-analysis carried out using the data of three patient groups from a previously published study Kamboh et al. and from our study. The results indicated that, compared with all the other APOE genotypes, those carrying the Leu28-->Pro mutation were at a substantially higher risk of developing AD (OR=4.25; 95% CI=1.21-14.97).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12498968     DOI: 10.1016/s0197-4580(02)00089-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  3 in total

1.  The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.

Authors:  Bruno A Benitez; Celeste M Karch; Yefei Cai; Sheng Chih Jin; Breanna Cooper; David Carrell; Sarah Bertelsen; Lori Chibnik; Julie A Schneider; David A Bennett; Anne M Fagan; David Holtzman; John C Morris; Alison M Goate; Carlos Cruchaga
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

2.  Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.

Authors:  Letta Argyri; Ioannis Dafnis; Theodossis A Theodossiou; Donald Gantz; Efstratios Stratikos; Angeliki Chroni
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

3.  ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease.

Authors:  Christopher W Medway; Samer Abdul-Hay; Tynickwa Mims; Li Ma; Gina Bisceglio; Fanggeng Zou; Shane Pankratz; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Joanna Siuda; Zbigniew K Wszolek; Owen A Ross; Minerva Carrasquillo; Dennis W Dickson; Neill Graff-Radford; Ronald C Petersen; Nilüfer Ertekin-Taner; Kevin Morgan; Guojun Bu; Steven G Younkin
Journal:  Mol Neurodegener       Date:  2014-03-10       Impact factor: 14.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.